Low incidence of serum neutralizing factors in patients receiving recombinant alfa-2b interferon (intron a)

Recombinant Leukocyte A Interferon: Pharmacokinetics, Single-Dose Tolerance, and Biologic Effects in Cancer Patients

Jordan U. Gutterman, Seymour H. Fine, Jorge R. Quesada et al. · Annals of Internal Medicine · 1982 · 379 citations

Pharmacy, Oncology, Pharmacokinetics +17

Preliminary Observations on the Effect of Recombinant Leukocyte a Interferon in Homosexual Men with Kaposi's Sarcoma

Susan E. Krown, Francisco X. Real, Susanna Cunningham–Rundles et al. · New England Journal of Medicine · 1983 · 358 citations

Medicine, Immunology, Oncology +16

Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma.

Jorge R. Quesada, Adan Rios, David A. Swanson et al. · Journal of Clinical Oncology · 1985 · 273 citations

Medicine, Oncology, Cancer Immunology +14

Interferon-neutralizing antibodies in a patient treated with human fibroblast interferon

Angelika Vallbracht, J. Treuner, Bertram Flehmig et al. · Nature · 1981 · 165 citations

Life Sciences, Immunology, Clinical Immunology +4

Intranasal interferon-alpha 2 for prevention of natural rhinovirus colds

Barry M. Farr, Jack M. Gwaltney, Kate Adams et al. · Antimicrobial Agents and Chemotherapy · 1984 · 104 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15